Ask AI

Interactive Decision Support Tool

Share

Program Content

Activities

  • Moderate to Severe Atopic Dermatitis Treatment Selection
    Individualizing Therapy for Patients With Moderate to Severe Atopic Dermatitis While Emphasizing the Importance and Role of Biologics
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 19, 2025

    Expires: June 18, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association.

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

National Eczema Association

ProCE Banner

Practicing Clinicians Exchange, LLC

ProCE Banner